First, we showed that treatment with mild MHT induces increased expression of DNAM-1 and NKp30 ligands and downregulation of MHC molecules in U87 human GBM cells, thereby potentially enhancing their susceptibility to NK cell-mediated killing. Here, CD226 is linked to glioblastoma.